Altermed ApS: Financial statements 2023
CVR: 42504831
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Altermed ApS (CVR 42504831) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,063,221 and a net result of DKK 784,777 compared with DKK 683,291 the year before. That is an increase of 8.1% compared with the year before. Equity in the 2023 report amounted to DKK 4,449,846. The solvency ratio was 75.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,063,221
- Profit/Loss
- DKK 784,777
- Equity
- DKK 4,449,846
- Total Assets
- DKK 5,896,933
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.1 mio. | 785 t. | 4.4 mio. | 2 |
| 2022 | - | 1.9 mio. | 683 t. | 3.7 mio. | 2 |
| 2021 | - | 2.9 mio. | 1.5 mio. | 3 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Altermed ApS has published its annual report for 2022. Gross profit came to DKK 1,909,176, and the net result was DKK 683,291.
About Altermed ApS
Altermed ApS is a Danish company of the type Anpartsselskab based in Viborg, founded in 2021. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The management consists of Jesper Ahrendt Boel. The company is owned by Jesper Ahrendt Boel. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 2,401,366 and a net result of DKK 174,635 compared with DKK 377,094 the year before. Equity in the 2025 report amounted to DKK 4,645,911.